MiR-340 is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia
Frontiers in Oncology（2019）
Key words
miR-340,acute myeloid leukemia,clinical outcome,chemotherapy,allo-HCST
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined